https://stock.noler.com/us/stock/human-genome-sciences-inc https://stock.noler.com/us/stock/human-genome-sciences-inc/accounts-payable https://stock.noler.com/us/stock/human-genome-sciences-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/human-genome-sciences-inc/accounts-receivable https://stock.noler.com/us/stock/human-genome-sciences-inc/accumulated-depreciation https://stock.noler.com/us/stock/human-genome-sciences-inc/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/human-genome-sciences-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/human-genome-sciences-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/human-genome-sciences-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/human-genome-sciences-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/human-genome-sciences-inc/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities-other https://stock.noler.com/us/stock/human-genome-sciences-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/human-genome-sciences-inc/amended-reports-10-k https://stock.noler.com/us/stock/human-genome-sciences-inc/amended-reports-10-q https://stock.noler.com/us/stock/human-genome-sciences-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/human-genome-sciences-inc/aoci https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-current https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-gross-realized-gains https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-gross-realized-gains-losses-sale-proceeds https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-gross-realized-losses https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-securities https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-unrealized-loss-position-12-months-or-longer-aggregate-losses https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-unrealized-loss-position-aggregate-losses https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-unrealized-loss-position-fair-value https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-unrealized-loss-position-less-than-12-months-aggregate-losses https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/human-genome-sciences-inc/available-for-sale-unrealized-loss-position-twelve-months-or-longer-fair-value https://stock.noler.com/us/stock/human-genome-sciences-inc/basic-shares https://stock.noler.com/us/stock/human-genome-sciences-inc/business-exit-costs https://stock.noler.com/us/stock/human-genome-sciences-inc/buybacks-form-sc-13e4 https://stock.noler.com/us/stock/human-genome-sciences-inc/buybacks-form-sc-to-i https://stock.noler.com/us/stock/human-genome-sciences-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/human-genome-sciences-inc/capital-expenditures https://stock.noler.com/us/stock/human-genome-sciences-inc/cash-and-equivalents https://stock.noler.com/us/stock/human-genome-sciences-inc/cash-flow-breakdown https://stock.noler.com/us/stock/human-genome-sciences-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/human-genome-sciences-inc/clinical-trials https://stock.noler.com/us/stock/human-genome-sciences-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/human-genome-sciences-inc/common-stock-value https://stock.noler.com/us/stock/human-genome-sciences-inc/comprehensive-income https://stock.noler.com/us/stock/human-genome-sciences-inc/convertible-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/convertible-debt-current https://stock.noler.com/us/stock/human-genome-sciences-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/human-genome-sciences-inc/convertible-securities-retired https://stock.noler.com/us/stock/human-genome-sciences-inc/convertible-subordinated-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/convertible-subordinated-debt-current https://stock.noler.com/us/stock/human-genome-sciences-inc/convertible-subordinated-debt-noncurrent https://stock.noler.com/us/stock/human-genome-sciences-inc/cost-of-goods-sold https://stock.noler.com/us/stock/human-genome-sciences-inc/cost-of-services https://stock.noler.com/us/stock/human-genome-sciences-inc/costs-and-expenses https://stock.noler.com/us/stock/human-genome-sciences-inc/costs-in-excess-of-billings-on-uncompleted-contracts-or-programs-expected-to-be-collected-after-one-year https://stock.noler.com/us/stock/human-genome-sciences-inc/costs-in-excess-of-billings-on-uncompleted-contracts-or-programs-expected-to-be-collected-within-one-year https://stock.noler.com/us/stock/human-genome-sciences-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/human-genome-sciences-inc/current-assets https://stock.noler.com/us/stock/human-genome-sciences-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/human-genome-sciences-inc/current-liabilities https://stock.noler.com/us/stock/human-genome-sciences-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-carrying-amount https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-face-amount https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-interest-rate https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-longterm-and-shortterm-combined-amount https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/human-genome-sciences-inc/debt-unamortized-discount https://stock.noler.com/us/stock/human-genome-sciences-inc/deferred-rent-credit https://stock.noler.com/us/stock/human-genome-sciences-inc/deferred-revenue https://stock.noler.com/us/stock/human-genome-sciences-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/human-genome-sciences-inc/depreciation https://stock.noler.com/us/stock/human-genome-sciences-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/human-genome-sciences-inc/diluted-shares https://stock.noler.com/us/stock/human-genome-sciences-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/human-genome-sciences-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/human-genome-sciences-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/human-genome-sciences-inc/financing-cash-flow https://stock.noler.com/us/stock/human-genome-sciences-inc/gain-loss-on-sale-of-equity-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/general-and-administrative-expense https://stock.noler.com/us/stock/human-genome-sciences-inc/impairment-of-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/income-tax https://stock.noler.com/us/stock/human-genome-sciences-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/human-genome-sciences-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/human-genome-sciences-inc/income-taxes-paid https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-accrued-salaries https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/human-genome-sciences-inc/increase-decrease-of-restricted-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/human-genome-sciences-inc/insider-transactions-other https://stock.noler.com/us/stock/human-genome-sciences-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/human-genome-sciences-inc/interest-expense https://stock.noler.com/us/stock/human-genome-sciences-inc/interest-expense-on-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/interest-paid https://stock.noler.com/us/stock/human-genome-sciences-inc/inventory https://stock.noler.com/us/stock/human-genome-sciences-inc/inventory-noncurrent https://stock.noler.com/us/stock/human-genome-sciences-inc/inventory-work-in-process-and-raw-materials https://stock.noler.com/us/stock/human-genome-sciences-inc/investing-cash-flow https://stock.noler.com/us/stock/human-genome-sciences-inc/investment-income-interest https://stock.noler.com/us/stock/human-genome-sciences-inc/investment-income-net https://stock.noler.com/us/stock/human-genome-sciences-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/human-genome-sciences-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/human-genome-sciences-inc/long-term-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/net-change-in-cash https://stock.noler.com/us/stock/human-genome-sciences-inc/net-income https://stock.noler.com/us/stock/human-genome-sciences-inc/new-claims-filed-number https://stock.noler.com/us/stock/human-genome-sciences-inc/notes-payable-fair-value-disclosure https://stock.noler.com/us/stock/human-genome-sciences-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/human-genome-sciences-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/human-genome-sciences-inc/oci-securities-sale-reclassification-net-of-tax https://stock.noler.com/us/stock/human-genome-sciences-inc/oci-securities-sale-reclassification-net-of-tax-2 https://stock.noler.com/us/stock/human-genome-sciences-inc/oci-tax https://stock.noler.com/us/stock/human-genome-sciences-inc/oci-unrealized-holding-gain-loss-on-securities-arising-before-tax https://stock.noler.com/us/stock/human-genome-sciences-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-cash-flow https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-income https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-lease-payments-due https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/human-genome-sciences-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/human-genome-sciences-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/human-genome-sciences-inc/other-current-liabilities https://stock.noler.com/us/stock/human-genome-sciences-inc/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/human-genome-sciences-inc/other-noncash-income-expense https://stock.noler.com/us/stock/human-genome-sciences-inc/other-noncurrent-assets https://stock.noler.com/us/stock/human-genome-sciences-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/human-genome-sciences-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/human-genome-sciences-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/human-genome-sciences-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/human-genome-sciences-inc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/human-genome-sciences-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/human-genome-sciences-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/human-genome-sciences-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/human-genome-sciences-inc/payments-to-acquire-restricted-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/preferred-shares-facts https://stock.noler.com/us/stock/human-genome-sciences-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/human-genome-sciences-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/human-genome-sciences-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/human-genome-sciences-inc/preferred-stock-value https://stock.noler.com/us/stock/human-genome-sciences-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/human-genome-sciences-inc/prepaid-expense-current https://stock.noler.com/us/stock/human-genome-sciences-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-issuance-of-senior-long-term-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-sale-of-equity-method-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-sale-of-restricted-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/human-genome-sciences-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/human-genome-sciences-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/human-genome-sciences-inc/property-plant-equipment https://stock.noler.com/us/stock/human-genome-sciences-inc/public-float https://stock.noler.com/us/stock/human-genome-sciences-inc/realized-gain-loss-on-marketable-securities-cost-method-investments-and-other-investments https://stock.noler.com/us/stock/human-genome-sciences-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/research-and-development https://stock.noler.com/us/stock/human-genome-sciences-inc/restricted-investments-noncurrent https://stock.noler.com/us/stock/human-genome-sciences-inc/restructuring-reserve https://stock.noler.com/us/stock/human-genome-sciences-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/human-genome-sciences-inc/restructuring-reserve-change https://stock.noler.com/us/stock/human-genome-sciences-inc/restructuring-reserve-current https://stock.noler.com/us/stock/human-genome-sciences-inc/restructuring-reserve-period-expense https://stock.noler.com/us/stock/human-genome-sciences-inc/restructuring-reserve-settled-with-cash https://stock.noler.com/us/stock/human-genome-sciences-inc/retained-earnings https://stock.noler.com/us/stock/human-genome-sciences-inc/revenue https://stock.noler.com/us/stock/human-genome-sciences-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/human-genome-sciences-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/human-genome-sciences-inc/sales-revenue-services-net https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-10-k https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-10-q https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-11-k https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-15-12b https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-25-nse https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-8-k https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-ct-order https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-def-14a https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-defa14a https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-defr14a https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-defs14a https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-pres14a https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-s-4 https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/human-genome-sciences-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-424b7 https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-pos-ex https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-posasr https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/human-genome-sciences-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/human-genome-sciences-inc/senior-long-term-notes https://stock.noler.com/us/stock/human-genome-sciences-inc/sga-expense https://stock.noler.com/us/stock/human-genome-sciences-inc/shareholders-equity https://stock.noler.com/us/stock/human-genome-sciences-inc/shares-authorized https://stock.noler.com/us/stock/human-genome-sciences-inc/shares-issued https://stock.noler.com/us/stock/human-genome-sciences-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/human-genome-sciences-inc/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-discount-from-market-price-purchase-date https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-fair-value-assumptions-expected-term https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-rsu-forfeited-in-period-grant-date-fair-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-based-compensation https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-compensation-unrecognized-cost-recognition-period https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-exercisable-remaining-term https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-outstanding-remaining-term https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/human-genome-sciences-inc/stock-options-vested-and-expected-to-vest-outstanding-remaining-term https://stock.noler.com/us/stock/human-genome-sciences-inc/subordinated-borrowing-interest-rate https://stock.noler.com/us/stock/human-genome-sciences-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/human-genome-sciences-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/human-genome-sciences-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/human-genome-sciences-inc/tax-reconciliation-deductions-other https://stock.noler.com/us/stock/human-genome-sciences-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/human-genome-sciences-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/human-genome-sciences-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/human-genome-sciences-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/human-genome-sciences-inc/total-assets https://stock.noler.com/us/stock/human-genome-sciences-inc/total-liabilities https://stock.noler.com/us/stock/human-genome-sciences-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/human-genome-sciences-inc/total-long-term-debt https://stock.noler.com/us/stock/human-genome-sciences-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/human-genome-sciences-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/human-genome-sciences-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/human-genome-sciences-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/human-genome-sciences-inc/valuation-allowance-amount https://stock.noler.com/us/stock/human-genome-sciences-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/human-genome-sciences-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/human-genome-sciences-inc/weighted-average-number-of-shares-outstanding-basic-and-diluted